127 related articles for article (PubMed ID: 35961847)
21. Smaller decline of renal function after nephroureterectomy predicts poorer prognosis of upper tract urothelial carcinoma: a multicentre retrospective study.
Yamada Y; Nakagawa T; Miyakawa J; Kawai T; Tabata M; Kaneko T; Taguchi S; Naito A; Hikatsu M; Sato Y; Murata T; Matsumoto A; Miyazaki H; Suzuki M; Enomoto Y; Nishimatsu H; Kondo Y; Takeuchi T; Tanaka Y; Kume H
Jpn J Clin Oncol; 2021 Oct; 51(10):1577-1586. PubMed ID: 34047345
[TBL] [Abstract][Full Text] [Related]
22. Oncological Outcomes of Laparoscopic Nephroureterectomy Versus Open Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: An European Association of Urology Guidelines Systematic Review.
Peyronnet B; Seisen T; Dominguez-Escrig JL; Bruins HM; Yuan CY; Lam T; Maclennan S; N'dow J; Babjuk M; Comperat E; Zigeuner R; Sylvester RJ; Burger M; Mostafid H; van Rhijn BWG; Gontero P; Palou J; Shariat SF; Roupret M
Eur Urol Focus; 2019 Mar; 5(2):205-223. PubMed ID: 29154042
[TBL] [Abstract][Full Text] [Related]
23. Two cycles of neoadjuvant chemotherapy improves survival in patients with high-risk upper tract urothelial carcinoma.
Zennami K; Sumitomo M; Takahara K; Nukaya T; Takenaka M; Fukaya K; Ichino M; Fukami N; Sasaki H; Kusaka M; Shiroki R
BJU Int; 2021 Mar; 127(3):332-339. PubMed ID: 32896105
[TBL] [Abstract][Full Text] [Related]
24. Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756).
Calleris G; Rouprêt M; Seisen T; Bendjeddou L; Chevallier T; Masson-Lecomte A; Thibault C; Neuzillet Y; Audenet F; Xylinas E; Houédé N
World J Urol; 2023 Dec; 41(12):3413-3420. PubMed ID: 37698632
[TBL] [Abstract][Full Text] [Related]
25. [Preoperative chemotherapy for patients with upper tract urothelial carcinoma: Impact on renal function].
Gabriel PE; Lambert T; Dumont C; Gauthier H; Masson-Lecomte A; Culine S
Prog Urol; 2023 Aug; 33(8-9):446-455. PubMed ID: 37414668
[TBL] [Abstract][Full Text] [Related]
26. Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma.
Margulis V; Puligandla M; Trabulsi EJ; Plimack ER; Kessler ER; Matin SF; Godoy G; Alva A; Hahn NM; Carducci MA; Hoffman-Censits J;
J Urol; 2020 Apr; 203(4):690-698. PubMed ID: 31702432
[TBL] [Abstract][Full Text] [Related]
27. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
[TBL] [Abstract][Full Text] [Related]
28. Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma.
D'Andrea D; Matin S; Black PC; Petros FG; Zargar H; Dinney CP; Cookson MS; Kassouf W; Dall'Era MA; McGrath JS; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; Sridhar SS; North S; Barocas DA; Lotan Y; Stephenson AJ; van Rhijn BW; Spiess PE; Daneshmand S; Shariat SF
BJU Int; 2021 May; 127(5):528-537. PubMed ID: 32981193
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of BCG for non-muscle invasive bladder cancer following nephroureterectomy for upper tract urothelial carcinoma.
Massari M; O'Malley P; Benidir T; Su LM; Gao H; Crispen PL
Urol Oncol; 2024 Sep; 42(9):289.e7-289.e12. PubMed ID: 38802293
[TBL] [Abstract][Full Text] [Related]
30. Prevalence and oncologic impact of chronic kidney disease for upper tract urothelial carcinoma in endemic area.
Lee IW; Wang HJ; Liu HY; Chang YL; Wu YT; Chen YT; Cheng YT; Kang CH; Chuang YC; Luo HL
J Formos Med Assoc; 2024 Jul; 123(7):758-763. PubMed ID: 38044211
[TBL] [Abstract][Full Text] [Related]
31. Chemotherapy increases survival and downstaging of upper tract urothelial cancer.
Davaro F; May A; McFerrin C; Raza SJ; Siddiqui S; Hamilton Z
Can J Urol; 2019 Oct; 26(5):9938-9944. PubMed ID: 31629443
[TBL] [Abstract][Full Text] [Related]
32. Effects of different combinations of radical nephroureterectomy and bladder cuff excision procedures for upper tract urothelial carcinoma on bladder recurrence.
Huang EY; Tai MC; Chung HJ; Chang YH; Huang WJ
Int Braz J Urol; 2023; 49(4):469-478. PubMed ID: 37267612
[TBL] [Abstract][Full Text] [Related]
33. Advanced chronic kidney disease; A comparison between nephroureterectomy and nephron-sparing surgery for upper tract urothelial carcinoma.
Dudinec JV; Ortiz-Melo DI; Lipkin ME; Abern MR; Shah AM; Inman BA
Urol Oncol; 2023 Jun; 41(6):295.e19-295.e25. PubMed ID: 36526526
[TBL] [Abstract][Full Text] [Related]
34. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma.
Adibi M; McCormick B; Economides MP; Petros F; Xiao L; Guo C; Shah A; Kamat AM; Dinney C; Navai N; Gao J; Siefker-Radtke A; Matin SF; Campbell MT
Clin Genitourin Cancer; 2022 Apr; 20(2):176-182. PubMed ID: 35039231
[TBL] [Abstract][Full Text] [Related]
35. Optimal Timing of Chemotherapy and Surgery in Patients with Muscle-Invasive Bladder Cancer and Upper Urinary Tract Urothelial Carcinoma.
Tabayoyong W; Li R; Gao J; Kamat A
Urol Clin North Am; 2018 May; 45(2):155-167. PubMed ID: 29650132
[TBL] [Abstract][Full Text] [Related]
36. Variant histology is associated with more non-urothelial tract recurrence but less intravesical recurrence for upper tract urothelial carcinoma after radical nephroureterectomy.
Yu TY; Wang HJ; Sung MT; Chuang YC; Chen YT; Cheng YT; Kang CH; Liu HY; Chang YL; Luo HL
Int J Urol; 2024 Apr; 31(4):410-418. PubMed ID: 38169055
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic ureteroscopy prior to nephroureterectomy for urothelial carcinoma is associated with a high risk of bladder recurrence despite technical precautions to avoid tumor spillage.
Baboudjian M; Al-Balushi K; Michel F; Lannes F; Akiki A; Gaillet S; Delaporte V; Ragni E; Toledano H; Karsenty G; Rossi D; Bastide C; Lechevallier E; Boissier R
World J Urol; 2020 Jan; 38(1):159-165. PubMed ID: 30993427
[TBL] [Abstract][Full Text] [Related]
38. Segmental Ureterectomy Versus Radical Nephroureterectomy in Older Patients Treated for Upper Tract Urothelial Carcinoma.
Abrate A; Sessa F; Sessa M; Campi R; Sebastianelli A; Varca V; Pavone C; Vella M; Bartoletti R; Ficarra V; Serni S; Brunocilla E; Gregori A; Trombetta C; Lissiani A; Terrone C; Gontero P; Schiavina R; Gacci M; Simonato A
Clin Genitourin Cancer; 2022 Aug; 20(4):381-387. PubMed ID: 35125302
[TBL] [Abstract][Full Text] [Related]
39. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
[TBL] [Abstract][Full Text] [Related]
40. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).
Tafuri A; Marchioni M; Cerrato C; Mari A; Tellini R; Odorizzi K; Veccia A; Amparore D; Shakir A; Carbonara U; Panunzio A; Trovato F; Catellani M; Janello LMI; Bianchi L; Novara G; Dal Moro F; Schiavina R; De Lorenzis E; Parma P; Cimino S; De Cobelli O; Maiorino F; Bove P; Crocerossa F; Cantiello F; D'Andrea D; Di Cosmo F; Porpiglia F; Ditonno P; Montanari E; Soria F; Gontero P; Liguori G; Trombetta C; Mantica G; Borghesi M; Terrone C; Del Giudice F; Sciarra A; Galosi A; Moschini M; Shariat SF; Di Nicola M; Minervini A; Ferro M; Cerruto MA; Schips L; Pagliarulo V; Antonelli A
World J Urol; 2022 Nov; 40(11):2771-2779. PubMed ID: 36203101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
